Cite
MLA Citation
Jeremy M. Shefner et al.. “A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.” Amyotrophic lateral sclerosis and frontotemporal degeneration, vol. 22, no. 3, 2021, pp. 287–299. http://access.bl.uk/ark:/81055/vdc_100129517288.0x000006